DTIL
Precision Biosciences IncCompany with tickers: DTIL
CIK
1357874
CUSIP
74019P207
Shares Outstanding
25,802,247
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-20 | Germano Geno J | Director | Convert | 21,000 |
| 2026-05-20 | Germano Geno J | Director | Convert | 21,000 |
| 2026-05-20 | Pire Shari Lisa | Director | Convert | 21,000 |
| 2026-05-20 | Pire Shari Lisa | Director | Convert | 21,000 |
| 2026-05-20 | Brown Melinda | Director | Convert | 21,000 |
| 2026-05-20 | Brown Melinda | Director | Convert | 21,000 |
| 2026-05-20 | Frankel Stanley | Director | Convert | 21,000 |
| 2026-05-20 | Frankel Stanley | Director | Convert | 21,000 |
| 2026-05-20 | Buehler Kevin | Director | Convert | 21,000 |
| 2026-05-20 | Buehler Kevin | Director | Convert | 21,000 |
| 2026-02-18 | Amoroso Michael | Director | Sell | 20,559 |
| 2026-02-18 | Scimeca Dario | General Counsel and Secretary | Sell | 4,925 |
| 2026-02-18 | SMITH J. JEFFERSON | Chief Research Officer | Sell | 4,925 |
| 2026-02-18 | Kelly John Alexander | Chief Financial Officer | Sell | 8,149 |
| 2026-02-17 | Amoroso Michael | Director | Convert | 67,797 |
| 2026-02-17 | Amoroso Michael | Director | Convert | 67,797 |
| 2026-02-17 | Scimeca Dario | General Counsel and Secretary | Convert | 16,667 |
| 2026-02-17 | Scimeca Dario | General Counsel and Secretary | Convert | 16,667 |
| 2026-02-17 | SMITH J. JEFFERSON | Chief Research Officer | Convert | 16,667 |
| 2026-02-17 | SMITH J. JEFFERSON | Chief Research Officer | Convert | 16,667 |
| 2026-02-17 | SMITH J. JEFFERSON | Chief Research Officer | Other | 7,931 |
| 2026-02-17 | Kelly John Alexander | Chief Financial Officer | Convert | 27,584 |
| 2026-02-17 | Kelly John Alexander | Chief Financial Officer | Convert | 27,584 |
| 2026-01-22 | Amoroso Michael | Director | Sell | 34,799 |
| 2026-01-21 | Kelly John Alexander | Chief Financial Officer | Sell | 15,213 |
| 2026-01-21 | SMITH J. JEFFERSON | Chief Research Officer | Convert | 16,219 |
| 2026-01-21 | SMITH J. JEFFERSON | Chief Research Officer | Sell | 10,200 |
| 2026-01-21 | Scimeca Dario | General Counsel and Secretary | Sell | 8,854 |
| 2026-01-20 | Kelly John Alexander | Chief Financial Officer | Convert | 3,888 |
| 2026-01-20 | Kelly John Alexander | Chief Financial Officer | Convert | 26,575 |
| 2026-01-20 | Kelly John Alexander | Chief Financial Officer | Convert | 26,575 |
| 2026-01-20 | Kelly John Alexander | Chief Financial Officer | Convert | 3,888 |
| 2026-01-20 | Kelly John Alexander | Chief Financial Officer | Convert | 13,900 |
| 2026-01-20 | Kelly John Alexander | Chief Financial Officer | Convert | 13,900 |
| 2026-01-20 | SMITH J. JEFFERSON | Chief Research Officer | Convert | 10,447 |
| 2026-01-20 | SMITH J. JEFFERSON | Chief Research Officer | Convert | 16,219 |
| 2026-01-20 | SMITH J. JEFFERSON | Chief Research Officer | Convert | 10,447 |
| 2026-01-20 | SMITH J. JEFFERSON | Chief Research Officer | Convert | 2,500 |
| 2026-01-20 | SMITH J. JEFFERSON | Chief Research Officer | Convert | 2,500 |
| 2026-01-20 | SMITH J. JEFFERSON | Chief Research Officer | Other | 7,931 |
| 2026-01-20 | Amoroso Michael | Director | Convert | 69,421 |
| 2026-01-20 | Amoroso Michael | Director | Convert | 8,888 |
| 2026-01-20 | Amoroso Michael | Director | Convert | 37,069 |
| 2026-01-20 | Amoroso Michael | Director | Convert | 37,069 |
| 2026-01-20 | Amoroso Michael | Director | Convert | 69,421 |
| 2026-01-20 | Amoroso Michael | Director | Convert | 8,888 |
| 2026-01-20 | Scimeca Dario | General Counsel and Secretary | Convert | 1,978 |
| 2026-01-20 | Scimeca Dario | General Counsel and Secretary | Convert | 14,908 |
| 2026-01-20 | Scimeca Dario | General Counsel and Secretary | Convert | 8,425 |
| 2026-01-20 | Scimeca Dario | General Counsel and Secretary | Convert | 14,908 |
| 2026-01-20 | Scimeca Dario | General Counsel and Secretary | Convert | 1,978 |
| 2026-01-20 | Scimeca Dario | General Counsel and Secretary | Convert | 8,425 |
| 2025-12-16 | Germano Geno J | Director | Buy | 3,000 |
| 2025-12-16 | Frankel Stanley | Director | Buy | 2,700 |
| 2025-12-15 | Brown Melinda | Director | Buy | 1,381 |
| 2025-11-03 | Kelly John Alexander | Chief Financial Officer | Sell | 1,303 |
| 2025-11-03 | Scimeca Dario | General Counsel and Secretary | Sell | 665 |
| 2025-11-03 | Amoroso Michael | Director | Sell | 3,409 |
| 2025-11-03 | Amoroso Michael | Director | Convert | 9,444 |
| 2025-11-02 | Kelly John Alexander | Chief Financial Officer | Convert | 3,605 |
| 2025-11-02 | Kelly John Alexander | Chief Financial Officer | Convert | 3,605 |
| 2025-11-02 | Scimeca Dario | General Counsel and Secretary | Convert | 1,835 |
| 2025-11-02 | Scimeca Dario | General Counsel and Secretary | Convert | 1,835 |
| 2025-11-02 | Amoroso Michael | Director | Convert | 9,444 |
| 2025-09-26 | Frankel Stanley | Director | Buy | 2,700 |
| 2025-09-22 | Brown Melinda | Director | Buy | 1,400 |
| 2025-07-03 | Kelly John Alexander | Chief Financial Officer | Sell | 14,827 |
| 2025-06-25 | Brown Melinda | Director | Buy | 1,682 |
| 2025-06-25 | Buehler Kevin | Director | Buy | 5,076 |
| 2025-06-03 | Germano Geno J | Director | Award | 21,000 |
| 2025-06-03 | Pire Shari Lisa | Director | Award | 21,000 |
| 2025-06-03 | Frankel Stanley | Director | Award | 21,000 |
| 2025-06-03 | Buehler Kevin | Director | Award | 21,000 |
| 2025-06-03 | Brown Melinda | Director | Award | 21,000 |
| 2025-06-02 | Amoroso Michael | Director | Award | 203,390 |
| 2025-06-02 | SMITH J. JEFFERSON | Chief Research Officer | Award | 50,000 |
| 2025-06-02 | Scimeca Dario | General Counsel and Secretary | Award | 50,000 |
| 2025-06-02 | Kelly John Alexander | Chief Financial Officer | Award | 82,750 |
| 2025-05-27 | Germano Geno J | Director | Convert | 9,826 |
| 2025-05-27 | Germano Geno J | Director | Convert | 9,826 |
| 2025-05-27 | Pire Shari Lisa | Director | Convert | 9,826 |
| 2025-05-27 | Pire Shari Lisa | Director | Convert | 9,826 |
| 2025-05-27 | Frankel Stanley | Director | Convert | 9,826 |
| 2025-05-27 | Frankel Stanley | Director | Convert | 9,826 |
| 2025-05-27 | Buehler Kevin | Director | Convert | 9,826 |
| 2025-05-27 | Buehler Kevin | Director | Convert | 9,826 |
| 2025-05-27 | Brown Melinda | Director | Convert | 9,826 |
| 2025-05-27 | Brown Melinda | Director | Convert | 9,826 |
| 2025-03-26 | Brown Melinda | Director | Buy | 1,839 |
| 2025-03-26 | Buehler Kevin | Director | Buy | 4,523 |
| 2025-03-25 | Germano Geno J | Director | Buy | 3,250 |
| 2025-03-24 | Amoroso Michael | Director | Sell | 964 |
| 2025-03-21 | Amoroso Michael | Director | Convert | 3,417 |
| 2025-03-21 | Amoroso Michael | Director | Convert | 3,417 |
| 2025-03-04 | Scimeca Dario | General Counsel and Secretary | Sell | 272 |
| 2025-03-04 | SMITH J. JEFFERSON | Chief Research Officer | Sell | 154 |
| 2025-03-03 | Scimeca Dario | General Counsel and Secretary | Convert | 919 |
| 2025-03-03 | Scimeca Dario | General Counsel and Secretary | Convert | 919 |
| 2025-03-03 | SMITH J. JEFFERSON | Chief Research Officer | Convert | 519 |
| 2025-03-03 | SMITH J. JEFFERSON | Chief Research Officer | Other | 7,931 |